DR58.1 DataRelease

Release Date: November 2025
New Studies: 2
Updated Studies: 0

New Studies

SDY3299: UCI ACC Adjuvant Set #2
Status:	New
Description:	A side-by-side comparison of 5 novel combination adjuvants (Alhydroxyquim-II, T-VANT, TRAC-478, IVAX-1 and IVAX-3) each formulated with two approved seasonal influenza vaccines (Flublok and Fluzone HD) with assessment of innate and adaptive immune responses and efficacy against H1N1 challenge in female and male C57Bl/6 mice. Controls include FluAd, vaccine only, adjuvant only, and PBS.
Program/Contract:	Program Contract NIH Program Adjuvant Comparison and Characterization in Influenza , Chlamydia muridarum, and Coxiella burnetii Vaccines
DOI:	10.21430/M31MC4O87Y
Subjects:	433
Study PI, contact:	Name Organization Site Jenny Hernandez-Davies UC Irvine UC Irvine Vaccine Research Center Jiin Felgner UC Irvine UC Irvine Vaccine Research Center Erwin Strahsburger UC Irvine UC Irvine Vaccine Research Center Jacob Laster UC Irvine UC Irvine Vaccine Research Center Aarti Jain UC Irvine UC Irvine Vaccine Research Center Timothy Yates UC Irvine UC Irvine Vaccine Research Center Emily Silzel UC Irvine UC Irvine Vaccine Research Center Rafael Assis UC Irvine UC Irvine Vaccine Research Center Rie Nakajima UC Irvine UC Irvine Vaccine Research Center Algimantas Jasinskas UC Irvine UC Irvine Vaccine Research Center Andriy Yeromin UC Irvine UC Irvine Vaccine Research Center Egest Pone UC Irvine UC Irvine Vaccine Research Center Sharon Jan UC Irvine UC Irvine Vaccine Research Center Luis de la Maza UC Rivine UC Irvine Vaccine Research Center Li Liang UC Irvine UC Irvine Vaccine Research Center Philip Felgner UC Irvine UC Irvine Vaccine Research Center Lisa Wagar UC Irvine UC Irvine Vaccine Research Center Anthony Gregory UC Irvine UC Irvine Vaccine Research Center D. Huw Davies UC Irvine UC Irvine Vaccine Research Center
Publications:	None
Resources:
Assays:	Assay Type Number of Exp. Samples ELISA 140 Hemagglutination Inhibition 224 Microneutralization Assay 224 Other 17885
Clinical Assessments:	None

---

SDY3302: Innaptives
Status:	New
Description:	The panel described here was designed to quantify populations of cells that may influence protection against Mycobacterium tuberculosis (Mtb) infection in naïve control animals enrolled in pre-clinical NHP vaccine studies. This panel may be used to identify and assess unconventional T cell populations related to other disease models, such as cancer and HIV.
Program/Contract:	Program Contract NIH Program Internal NIAID Grant
DOI:	10.21430/M3GE6X8EP6
Subjects:	0
Study PI, contact:	Name Organization Site Kathryn Foulds NIAD NIC
Publications:	None
Resources:
Assays:	None
Clinical Assessments:	None

Updated Studies